

When migraine is present for much of the month, it can begin to shape working hours, family plans, sleep and confidence. Injections for chronic migraine are a preventative treatment designed for people whose migraine pattern has become frequent and disruptive, rather than an injection taken to stop a single attack once it has begun.
For the right person, this clinician-led approach may reduce the number of headache days and lessen the impact of attacks over time. It is not a quick fix, and it is not suitable for every type of headache. A careful medical assessment is the starting point, particularly where symptoms have changed, are severe or have not previously been investigated.
Chronic migraine is usually diagnosed when someone experiences headache on 15 or more days each month for at least three months, with migraine features on at least eight of those days. Those features might include throbbing pain, sensitivity to light or sound, nausea, visual disturbance, or pain that worsens with usual activity.
This is different from having an occasional migraine after a busy week or around hormonal changes. People with chronic migraine may feel as though there are very few genuinely clear days. They may also be relying more often on painkillers or migraine-specific medication, which can sometimes contribute to medication-overuse headache and make the overall pattern harder to manage.
A consultation should look beyond the number of headaches alone. Your clinician will discuss when symptoms began, where the pain occurs, associated symptoms, current medication, previous treatments and relevant medical history. New neurological symptoms, a sudden severe headache, headache after injury, or a significant change from your usual pattern should always be assessed promptly.
The treatment most commonly used is botulinum toxin type A, administered in small, precisely placed doses across particular areas of the forehead, temples, scalp, neck and upper shoulders. Although botulinum toxin is also widely recognised for wrinkle-reduction treatment, its use for chronic migraine has a distinct clinical purpose, injection pattern and dosing approach.
It is thought to work partly by reducing the release of chemical messengers involved in pain signalling around nerve endings. In practical terms, the aim is to make the nervous system less likely to sustain the cycle of frequent migraine. It is a preventative treatment, so it will not usually relieve a migraine that is already under way on the day of your appointment.
Treatment is generally repeated at intervals of around 12 weeks. Some people notice a change after their first session, while others need two or three treatment cycles before the benefit can be judged fairly. Response varies: a worthwhile result may mean fewer headache days, less severe attacks, reduced reliance on rescue medication, or simply more predictable days in which to work and make plans.
A doctor-led consultation allows the treatment plan to be based on your migraine history rather than a standard cosmetic protocol. You may be asked to keep a headache diary before treatment, recording headache days, migraine features, medication use and triggers where these are clear. This creates a useful baseline for reviewing whether treatment is helping.
Once suitability is confirmed, the injection appointment itself is usually straightforward. Very fine needles are used to place a series of small injections into mapped areas of the head and neck. The procedure is brief, and most patients describe the sensation as manageable pinching or stinging rather than significant pain.
There is normally little downtime. Small raised areas, pinpoint redness or tenderness can occur at injection sites and tend to settle quickly. You should receive individual aftercare advice, including when to resume exercise, facial treatments or other activities. Plans may need adjusting if you are having other injectable or skin procedures in similar areas.
Injections are usually considered for adults with a confirmed chronic migraine diagnosis, especially where established preventative medicines have not provided enough relief, have caused unacceptable side effects, or are not appropriate for medical reasons. They are one part of a wider management plan, not a replacement for investigating the cause of headaches or addressing clear contributing factors.
Suitability depends on individual circumstances. Pregnancy or breastfeeding, certain neurological or muscular conditions, an active infection at the proposed injection sites, allergy to ingredients, and some medicines may mean treatment should be delayed or avoided. Be open about all prescription medicines, supplements and previous reactions to injectables.
A clinician may also advise a different route if your symptoms are more consistent with tension-type headache, cluster headache, sinus-related symptoms, jaw clenching, neck pain or another cause. These conditions can overlap, which is precisely why a proper assessment matters. Teeth grinding, for example, may contribute to facial tension and headaches, but it is not automatically the same as chronic migraine.
The goal is improvement, not necessarily the complete disappearance of migraine. Some patients experience a meaningful reduction in monthly migraine days; others see only a modest change, and a smaller number do not respond sufficiently to continue. Your clinician should review the effect against your diary and your day-to-day functioning rather than promising a particular outcome.
It can also take time to identify the wider combination that works best. Sleep quality, hydration, meals, stress, hormonal patterns, caffeine use and medication frequency can all influence migraine for some people. Where appropriate, a GP, neurologist or other healthcare professional may remain an essential part of your care.
When administered by an appropriately qualified medical practitioner, migraine injections are generally well tolerated, but every prescription treatment carries potential risks. Temporary discomfort, bruising, headache, neck pain, heaviness around the forehead and localised muscle weakness can occur. Less commonly, treatment may lead to eyelid drooping or changes in facial expression, particularly if the product affects nearby muscles.
Serious reactions are uncommon but require urgent medical attention. Difficulty swallowing, speaking or breathing, widespread weakness, or signs of an allergic reaction should never be ignored. Your clinician should explain the risks relevant to you, obtain informed consent and provide clear guidance on how to seek support after treatment.
Choosing a medical setting is not simply about comfort. It means your history, medicines and symptoms can be considered properly, the product can be prescribed appropriately, and treatment can be delivered with the same attention to anatomy and safety expected of any clinical procedure. At SkinQure, this begins with a discreet, in-person assessment and a plan shaped around your health needs.
Bring details of previous migraine treatments, current medication and any headache diary you have kept. It is also helpful to describe the practical cost of migraine: days missed from work, cancelled commitments, sleep disruption and the number of days you need acute medication. These details can be more informative than pain scores alone.
Ask how success will be measured, when you should expect review, and what the next step would be if treatment is not effective enough. The most useful plan is one you can follow consistently and one that respects both the medical reality of migraine and the demands of your everyday life.
Frequent migraine should not simply become something you organise your life around. A considered consultation can clarify whether preventative injections are an appropriate option and help you move towards more manageable, more dependable days.